Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Amgen Inc (AMGN)

Amgen Inc (AMGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Amgen Inc ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320 USA

www.amgen.com Employees: 28,000 P: 805-447-1000

Sector:

Medical

Description:

Amgen Inc. is the leading biotech companies world wide, with a strong presence in the oncology/hematology, cardiovascular disease, neuroscience, inflammation, bone health & nephrology and neuroscience markets. It developed two most successful drugs, Epogen & Neupogen. Amgen successfully launched two next-generation products, Aranesp & Neulasta and also a biosimilar drug, Prolia/Xgeva. The acquisition of Immunex Corp gave Amgen access to the multi-blockbuster drug, Enbrel. Other products are Repatha, Blincyto, Parsabiv, Evenity, Aimovig, Lumakras/Lumykras, Kanjinti, Mvasi & Amgevita biosimilars. Amgen also has a promising pipeline of cancer drugs. It has one of the strongest cash positions in the biotech sector, which could be used to acquire more pipeline assets that could fuel long-term growth. The erythropoiesis-stimulating agents and granulocyte colony-stimulating factor franchise comprise Epogen/Aranesp and Neupogen/Neulasta respectively. Biosimilar drugs are also a key part of Amgen's growth strategy.

Key Statistics

Overview:

Market Capitalization, $K 202,015,744
Enterprise Value, $K 247,490,752
Shares Outstanding, K 539,068
Float, K 534,971
% Float 99.24%
Short Interest, K 13,263
Short Float 2.46%
Days to Cover 4.38
Short Volume Ratio 0.59
% of Insider Shareholders 0.76%
% of Institutional Shareholders 76.50%

Financials:

Annual Sales, $ 36,751 M
Annual Net Income, $ 7,711 M
Last Quarter Sales, $ 9,866 M
Last Quarter Net Income, $ 1,333 M
EBIT, $ 9,080 M
EBITDA, $ 14,672 M

Growth:

1-Year Return 24.83%
3-Year Return 60.38%
5-Year Return 66.61%
5-Year Revenue Growth 44.55%
5-Year Earnings Growth 31.57%
5-Year Dividend Growth 48.75%

Per-Share Information:

Most Recent Earnings 5.29 on 02/03/26
Next Earnings Date 05/07/26
Earnings Per Share ttm 21.85
EPS Growth vs. Prev Qtr -6.21%
EPS Growth vs. Prev Year -0.38%
Annual Dividend & Yield (Paid) 9.66 (2.58%)
Annual Dividend & Yield (Fwd) 10.08 (2.68%)
Most Recent Dividend 2.520 on 02/13/26
Next Ex-Dividends Date 02/13/26
Dividend Payable Date 03/06/26
Dividend Payout Ratio 43.28%
Most Recent Split 2-1 on 11/22/99

AMGN Ratios

Ratio
Price/Earnings ttm 17.19
Price/Earnings forward 16.79
Price/Earnings to Growth 3.80
Return-on-Equity % 148.37%
Return-on-Assets % 13.23%
Profit Margin % 20.98%
Debt/Equity 6.31
Price/Sales 5.51
Price/Cash Flow 11.11
Price/Book 23.35
Book Value/Share 16.08
Interest Coverage 4.26
60-Month Beta 0.46

AMGN Dividends

Date Value
02/13/26 $2.5200
11/21/25 $2.3800
08/22/25 $2.3800
05/16/25 $2.3800
02/14/25 $2.3800
11/18/24 $2.2500
08/16/24 $2.2500
05/16/24 $2.2500
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar